Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor ADuan, Lijuna; Yang, Zhanga; Jiang, Xiaa; Zhang, Jianhuab; Guo, XuyecAnti-Cancer Drugs: September 2019 - Volume 30 - Issue 8 - p 812–820 doi: 10.1097/CAD.0000000000000777 Preclinical Papers Buy Abstract Author InformationAuthors Article MetricsMetrics Oleanolic acid (OA) is a naturally occurring triterpenoid that possesses antitumor activity against several tumor cell lines. However, the potential mechanism underlying OA-induced thyroid carcinoma cell death is poorly understood. We investigated the biological functions of OA by performing migration, invasion, colony formation, and apoptosis assays on SW579 cells. Forkhead box A1 (FOXA1) expression was used to predict poor prognosis in patients with thyroid carcinoma among the TCGA samples from the UALCAN and gene expression profiling interactive analysis databases. Western blot was used to detect protein expression level. Results revealed that OA inhibited the migration, colony formation, and invasion of thyroid carcinoma cells in a dose-dependent manner. Further investigation verified that OA treatment induced significant apoptosis of thyroid carcinoma cells. Moreover, high FOXA1 expression predicted the poor prognosis of patients with thyroid cancer. The proliferation, migration, and invasion of thyroid carcinoma cells were significantly decreased when FOXA1 was silenced. OA significantly increased Akt phosphorylation and reduced FOXA1 expression in SW579 cells, but only PI3K/Akt inhibitor LY294002 attenuated OA-induced FOXA1 downregulation. Furthermore, Akt overexpression suppressed the FOXA1 expression in SW579 cells. In addition, molecular docking assay revealed that OA possessed high affinity toward FOXA1 with a low binding energy. OA may be a potential chemotherapeutic agent against thyroid carcinoma cells. aDepartment of Endocrinology, Tianjin First Center Hospital bTianjin University cDepartment of Medical Service, Tianjin Chest Hospital, Tianjin, China Received 30 October 2018 Revised form accepted 15 February 2019 Correspondence to Xuye Guo, MBBS, Department of Medical Service, Tianjin Chest Hospital, Tianjin 300222, China Tel: + 86 013 234 116 391; fax: +86 022 8818 5338; e-mail: firstname.lastname@example.org Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.